Santos David A 4

What Happened

• David A. Santos, EVP & Chief Commercial Officer of Rigel Pharmaceuticals (RIGL), delivered 5,718 shares on Feb 2, 2026 to satisfy a tax or exercise obligation. The shares were recorded as disposed at $36.01 per share, totaling about $205,905.
• This transaction is coded F (payment of exercise price or tax liability), meaning shares were withheld/delivered to cover taxes or option exercise costs rather than sold in an open-market trade.

Key Details

• Transaction date: 2026-02-02; Form 4 filed: 2026-02-04 (timely filing).
• Price per share: $36.01; total value: $205,905.
• Shares reported disposed: 5,718.
• Footnote: Includes 1,000 shares acquired under the issuer’s stock purchase plan.
• Shares owned after the transaction: not specified in the provided filing.

Context

• Code F transactions are typically tax-withholding or exercise-price payments (common after option exercises or receipt of awards) and do not necessarily indicate a market sale or change in insider sentiment.
• Retail investors should view this as a routine administrative transaction unless accompanied by open-market sales or additional disclosures.